Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).

Moritz Mirna; Alexander Lauten; Peter Jirak; Richard Rezar; Bernhard Wernly; Vera Paar; Thomas Felder; Uta Hoppe; Lukas Motloch; Christian Jung; Brunilda Alushi; Michael Lichtenauer; Hermann Salmhofer

doi:10.1016/j.ejim.2020.09.022

Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).

Moritz Mirna^* (First author)
, Alexander Lauten
, Peter Jirak (Co-author)
, Richard Rezar (Co-author)
, Bernhard Wernly (Co-author)
, Vera Paar (Co-author)
, Thomas Felder (Co-author)
, Uta Hoppe (Co-author)
, Lukas Motloch (Co-author)
, Christian Jung
, Brunilda Alushi
, Michael Lichtenauer (Last author)
, Hermann Salmhofer (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	98-107
Journal	EUROPEAN JOURNAL OF INTERNAL MEDICINE
Volume	85
DOIs	https://doi.org/10.1016/j.ejim.2020.09.022
Publication status	Published - 2021

Access to Document

10.1016/j.ejim.2020.09.022

Cite this

Mirna, M., Lauten, A., Jirak, P., Rezar, R., Wernly, B., Paar, V., Felder, T., Hoppe, U., Motloch, L., Jung, C., Alushi, B., Lichtenauer, M., & Salmhofer, H. (2021). Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR). EUROPEAN JOURNAL OF INTERNAL MEDICINE, 85, 98-107. https://doi.org/10.1016/j.ejim.2020.09.022

@article{32443362811b47938438d04b4945832b,

title = "Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).",

author = "Moritz Mirna and Alexander Lauten and Peter Jirak and Richard Rezar and Bernhard Wernly and Vera Paar and Thomas Felder and Uta Hoppe and Lukas Motloch and Christian Jung and Brunilda Alushi and Michael Lichtenauer and Hermann Salmhofer",

note = "Miran; Jirak; Rezar; Wernly; Paar; Hoppe; Motloc; Lichtenauer: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, M{\"u}llner Hauptstra{\ss}e 48, 5020 Salzburg, Austria; Felder: Department of Laboratory Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria; Salmhofer: Department of Internal Medicine I, Division of Gastroenterology and Nephrology, Paracelsus Medical University of Salzburg, Austria",

year = "2021",

doi = "10.1016/j.ejim.2020.09.022",

language = "English",

volume = "85",

pages = "98--107",

journal = "EUROPEAN JOURNAL OF INTERNAL MEDICINE",

issn = "0953-6205",

publisher = "Elsevier ",

}

Mirna, M, Lauten, A, Jirak, P, Rezar, R , Wernly, B , Paar, V , Felder, T , Hoppe, U, Motloch, L, Jung, C, Alushi, B, Lichtenauer, M & Salmhofer, H 2021, 'Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).', EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol. 85, pp. 98-107. https://doi.org/10.1016/j.ejim.2020.09.022

Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR). / Mirna, Moritz (First author); Lauten, Alexander; Jirak, Peter (Co-author) et al.
In: EUROPEAN JOURNAL OF INTERNAL MEDICINE, Vol. 85, 2021, p. 98-107.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).

AU - Mirna, Moritz

AU - Lauten, Alexander

AU - Jirak, Peter

AU - Rezar, Richard

AU - Wernly, Bernhard

AU - Paar, Vera

AU - Felder, Thomas

AU - Hoppe, Uta

AU - Motloch, Lukas

AU - Jung, Christian

AU - Alushi, Brunilda

AU - Lichtenauer, Michael

AU - Salmhofer, Hermann

N1 - Miran; Jirak; Rezar; Wernly; Paar; Hoppe; Motloc; Lichtenauer: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria; Felder: Department of Laboratory Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria; Salmhofer: Department of Internal Medicine I, Division of Gastroenterology and Nephrology, Paracelsus Medical University of Salzburg, Austria

PY - 2021

Y1 - 2021

U2 - 10.1016/j.ejim.2020.09.022

DO - 10.1016/j.ejim.2020.09.022

M3 - Original Article

C2 - 33191056

SN - 0953-6205

VL - 85

SP - 98

EP - 107

JO - EUROPEAN JOURNAL OF INTERNAL MEDICINE

JF - EUROPEAN JOURNAL OF INTERNAL MEDICINE

ER -